Advances in Genetic Editing of the Human Embryo

Author:

Astarăstoae Vasile1,Ioan Beatrice Gabriela1,Rogozea Liliana M.2,Hanganu Bianca1

Affiliation:

1. Faculty of Medicine, Grigore T Popa University of Medicine & Pharmacy Iasi, Romania; and

2. Basic, Preventive and Clinical Sciences Department, Transilvania University, Brasov, Romania

Abstract

Background: Genetic engineering has allowed a major development of research in this field, with specialists attempting to edit the human genome, after the successful editing of the genomes of plants and animals. However, human gene editing technologies are at the center of ethical debates around the world. Areas of Uncertainty: Ethical concerns about genetic editing of the human embryo raise several issues that can be viewed through the prism of optimism and reluctance leading to a number of recommendations regarding the acceptance of what may soon become a reality. Data Sources: A literature search was conducted through PubMed, MEDLINE, Plus, Scopus, and Web of Science (2015–2022) using combinations of keywords, including: human genome or gene editing plus ethics. Ethics and Therapeutic Advances: Gene therapy is seen by researchers as a way to solve congenital diseases, multifactorial diseases in general or specific diseases such as cystic fibrosis, muscular dystrophy, or can increase resistance to HIV infection. Genome editing technologies, germline gene editing, clustered regularly interspaced short palindromic repeats gene editing technology, technologies such as zinc finger nucleases are not only advanced gene therapies that require solving technical problems, but also techniques that require complex and complete analysis of ethical problems. Genetic engineering raises many ethical concerns such as: safety concerns especially the risk of off-target effects; autonomy of the individual—with the limitation of the future generations to consent for an intervention over their genome; social justice—keeping in mind the costs of the procedures and their availability to the general population. Discussions can go further from questions such as “How can we do this?” to questions such as “Should we do this?” or “Is society ready to accept this technology and is it able to manage it rationally?” Conclusions: The ethics of biomedical research should be based on global dialogue, on the involvement of experts and the public, to achieve a broad social consensus. The fundamental review of the ethics of genetics is a desire and an opportunity of the current period.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Ethical Dilemmas of Using Artificial Intelligence in Medicine;American Journal of Therapeutics;2024-04-25

2. The Nocebo Effect: A Bias in Clinical Practice—An Ethical Approach;American Journal of Therapeutics;2024-04-02

3. The New Mythology of the Body and the Transformation of the Therapeutic Space;American Journal of Therapeutics;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3